ARTICLE | Clinical News
Myodur regulatory update
February 9, 2004 8:00 AM UTC
XKEM filed for Orphan Drug designation for Myodur to treat muscular dystrophy. Myodur is a drug-targeting technology that uses carnitine, a membrane transport carrier molecule, to deliver leupeptin, a...